Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Beow Y Yeap

Showing results (61-70 of 176) with videos related to

Pageof 18
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 13, 2009
Impact of epidermal growth factor receptor and KRAS mutations on clinical outcomes in previously untreated non-small cell lung cancer patients: results of an online tumor registry of clinical trialsDavid M Jackman, Vincent A Miller, Leigh-Anne Cioffredi, et al.
Journal of the National Cancer Institute|April 30, 2009
Four-gene expression ratio test for survival in patients undergoing surgery for mesotheliomaGavin J Gordon, Lingsheng Dong, Beow Y Yeap, et al.
Lung Cancer (Amsterdam, Netherlands)|July 24, 2018
Clinical outcomes of patients with resected, early-stage ALK-positive lung cancerJamie E Chaft, Ibiayi Dagogo-Jack, Fernando C Santini, et al.
Blood|December 7, 2002
Quantitative real-time RT-PCR analysis of PML-RAR alpha mRNA in acute promyelocytic leukemia: assessment of prognostic significance in adult patients from intergroup protocol 0129Robert E Gallagher, Beow Y Yeap, Wanli Bi, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 1, 2006
Phase I to II study of pleurectomy/decortication and intraoperative intracavitary hyperthermic cisplatin lavage for mesotheliomaWilliam G Richards, Lambros Zellos, Raphael Bueno, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|October 2, 2022
Factors Associated With Developing Neurocognitive Adverse Events in Patients Receiving Lorlatinib After Progression on Other Targeted TherapiesIbiayi Dagogo-Jack, Antonello Abbattista, John F Murphy, et al.
Molecular Cancer Research : MCR|February 11, 2015
Adapting a drug screening platform to discover associations of molecular targeted radiosensitizers with genomic biomarkersQi Liu, Meng Wang, Ashley M Kern, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|June 21, 2007
Phase I trial of parathyroid hormone to facilitate stem cell mobilizationKaren K Ballen, Elizabeth J Shpall, David Avigan, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|September 12, 2018
Increased Hepatotoxicity Associated with Sequential Immune Checkpoint Inhibitor and Crizotinib Therapy in Patients with Non-Small Cell Lung CancerJessica J Lin, Emily Chin, Beow Y Yeap, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|February 18, 2014
Phase I study of urate oxidase in the reduction of acute graft-versus-host disease after myeloablative allogeneic stem cell transplantationAlbert C Yeh, Andrew M Brunner, Thomas R Spitzer, et al.
Pageof 18

Showing results (61-70 of 176) with videos related to

Sort By:
Pageof 18
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 13, 2009
Impact of epidermal growth factor receptor and KRAS mutations on clinical outcomes in previously untreated non-small cell lung cancer patients: results of an online tumor registry of clinical trialsDavid M Jackman, Vincent A Miller, Leigh-Anne Cioffredi, et al.
Journal of the National Cancer Institute|April 30, 2009
Four-gene expression ratio test for survival in patients undergoing surgery for mesotheliomaGavin J Gordon, Lingsheng Dong, Beow Y Yeap, et al.
Lung Cancer (Amsterdam, Netherlands)|July 24, 2018
Clinical outcomes of patients with resected, early-stage ALK-positive lung cancerJamie E Chaft, Ibiayi Dagogo-Jack, Fernando C Santini, et al.
Blood|December 7, 2002
Quantitative real-time RT-PCR analysis of PML-RAR alpha mRNA in acute promyelocytic leukemia: assessment of prognostic significance in adult patients from intergroup protocol 0129Robert E Gallagher, Beow Y Yeap, Wanli Bi, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 1, 2006
Phase I to II study of pleurectomy/decortication and intraoperative intracavitary hyperthermic cisplatin lavage for mesotheliomaWilliam G Richards, Lambros Zellos, Raphael Bueno, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|October 2, 2022
Factors Associated With Developing Neurocognitive Adverse Events in Patients Receiving Lorlatinib After Progression on Other Targeted TherapiesIbiayi Dagogo-Jack, Antonello Abbattista, John F Murphy, et al.
Molecular Cancer Research : MCR|February 11, 2015
Adapting a drug screening platform to discover associations of molecular targeted radiosensitizers with genomic biomarkersQi Liu, Meng Wang, Ashley M Kern, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|June 21, 2007
Phase I trial of parathyroid hormone to facilitate stem cell mobilizationKaren K Ballen, Elizabeth J Shpall, David Avigan, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|September 12, 2018
Increased Hepatotoxicity Associated with Sequential Immune Checkpoint Inhibitor and Crizotinib Therapy in Patients with Non-Small Cell Lung CancerJessica J Lin, Emily Chin, Beow Y Yeap, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|February 18, 2014
Phase I study of urate oxidase in the reduction of acute graft-versus-host disease after myeloablative allogeneic stem cell transplantationAlbert C Yeh, Andrew M Brunner, Thomas R Spitzer, et al.
Pageof 18